General Information of This Antigen (ID: TAR0UTVLX)
Antigen Name
Galectin-3-binding protein (LGALS3BP)
Gene Name
LGALS3BP
Gene ID
3959
Synonym
M2BP; Basement membrane autoantigen p105;Lectin galactoside-binding soluble 3-binding protein;Mac-2-binding protein;Tumor-associated antigen 90K
Sequence
MTPPRLFWVWLLVAGTQGVNDGDMRLADGGATNQGRVEIFYRGQWGTVCDNLWDLTDASV
VCRALGFENATQALGRAAFGQGSGPIMLDEVQCTGTEASLADCKSLGWLKSNCRHERDAG
VVCTNETRSTHTLDLSRELSEALGQIFDSQRGCDLSISVNVQGEDALGFCGHTVILTANL
EAQALWKEPGSNVTMSVDAECVPMVRDLLRYFYSRRIDITLSSVKCFHKLASAYGARQLQ
GYCASLFAILLPQDPSFQMPLDLYAYAVATGDALLEKLCLQFLAWNFEALTQAEAWPSVP
TDLLQLLLPRSDLAVPSELALLKAVDTWSWGERASHEEVEGLVEKIRFPMMLPEELFELQ
FNLSLYWSHEALFQKKTLQALEFHTVPFQLLARYKGLNLTEDTYKPRIYTSPTWSAFVTD
SSWSARKSQLVYQSRRGPLVKYSSDYFQAPSDYRYYPYQSFQTPQHPSFLFQDKRVSWSL
VYLPTIQSCWNYGFSCSSDELPVLGLTKSGGSDRTIAYENKALMLCEGLFVADVTDFEGW
KAAIPSALDTNSSKSTSSFPCPAGHFNGFRTVIRPFYLTNSSGVD

    Click to Show/Hide
Function
Promotes integrin-mediated cell adhesion. May stimulate host defense against viruses and tumor cells.

    Click to Show/Hide
Uniprot Entry
LG3BP_HUMAN
HGNC ID
HGNC:6564
KEGG ID
hsa:3959
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
Anti-LGALS3BP mAb 1959-sss
ADC Name Payload Target Linker ADC Info
MP-1959-ADC [1]
Maytansinoid
Microtubule (MT)
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
1959-SSS-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Undisclosed
1959-sss/DM4 [3]
Mertansine DM4
Microtubule (MT)
Undisclosed
MP-LGS-ADC [4]
Undisclosed
Undisclosed
Undisclosed
References
Ref 1 Mediapharma product pipeline
Ref 2 Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma. Cancers (Basel). 2020 Oct 15;12(10):2989. doi: 10.3390/cancers12102989.
Ref 3 Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma. Mol Oncol. 2023 Aug;17(8):1460-1473. doi: 10.1002/1878-0261.13453. Epub 2023 Jun 7.
Ref 4 Basic information about MP-LGS-ADC